1.
|
13 p, 1.2 MB |
Arterial Stiffness in Type 1 Diabetes : The Case for the Arterial Wall Itself as a Target Organ
/
González-Clemente, José-Miguel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Cano, Albert (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Albert Fàbregas, Lara (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Giménez-Palop, Olga (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Romero, Ana (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Berlanga Escalera, Eugenio (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Vendrell, Joan (Hospital Universitari Joan XXIII de Tarragona) ;
Llauradó, Gemma (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Universitat Autònoma de Barcelona
Arterial stiffness (AS) integrates the cumulative burden of known and unknown cardiovascular risk factors on the elastic wall of large arteries along the lifespan of an individual. As a marker of vascular aging, AS is an independent predictor of cardiovascular events and improves cardiovascular risk prediction when added to the Framingham Risk Score. [...]
2021 - 10.3390/jcm10163616
Journal of clinical medicine, Vol. 10 (august 2021)
|
|
2.
|
17 p, 921.2 KB |
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
/
Sauta, Elisabetta (Humanitas Clinical and Research Center (Itàlia)) ;
Robin, Marie (Department of Hematology and Bone Marrow Transplantation. Hôpital Saint-Louis (França)) ;
Bersanelli, Mateo (Department of Biomedical Sciences. Humanitas University) ;
Travaglino, Erica (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ;
Meggendorfer, Manje (Mll Munich Leukemia Laboratory) ;
Zhao, Lin-Pierre (Department of Hematology and Bone Marrow Transplantation. Hôpital Saint-Louis (França)) ;
Caballero Berrocal, Juan Carlos (Hematology Department. Hospital Universitario de Salamanca) ;
Sala, Claudia (Experimental. Diagnostic and Specialty Medicine. Dimes) ;
Maggioni, Giulia (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ;
Bernardi, Massimo (University Vita-Salute San Raffaele (Itàlia)) ;
Di Grazia, Carmen (Irccs Ospedale Policlinico San Martino) ;
Vago, Luca (University Vita-Salute San Raffaele (Itàlia)) ;
Rivoli, Giulia (Irccs Ospedale Policlinico San Martino) ;
Borin, Lorenza (Ospedale San Gerardo) ;
D'Amico, Saverio (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ;
Tentori, Cristina Astrid (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ;
Ubezio, Marta (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ;
Campagna, Alessia (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ;
Russo, Antonio (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ;
Mannina, Daniele (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ;
Lanino, Luca (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ;
Chiusolo, Patrizia (Università Cattolica Del Sacro Cuore) ;
Giaccone, Luisa (Department of Molecular Biotechnology and Health Sciences. University of Turin) ;
Voso, Maria Teresa (Tor Vergata University) ;
Riva, Maria (Asst Grande Ospedale Metropolitano Niguarda) ;
Oliva, Esther Natalie (Grande Ospedale Metropolitano Bianchi Melacrino Morelli) ;
Zampini, Matteo (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ;
Riva, Elena (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ;
Nibourel, Olivier (Chu Lille) ;
Bicchieri, Marinela (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ;
Bolli, Niccolo (Department of Oncology and Hemato-Oncology. University of Milan) ;
Rambaldi, Alessandro (Azienda Ospedaliera Papa Giovanni Xxiii) ;
Passamonti, Francesco (Department of Medicine and Surgery. University of Insubria) ;
Savevski, Victor (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ;
Santoro, Armando (Department of Biomedical Sciences. Humanitas University) ;
Germing, Ulrich (Department of Hematology. Heinrich-Heine-University. University Clinic) ;
Kordasti, Shahram (Hematology Department. DISCLIMO-Università Politecnica Delle Marche) ;
Santini, Valeria (University of Florence) ;
Diez-Campelo, María (Hospital Universitario de Salamanca) ;
Sanz, Guillermo (Hospital Universitario la Fe) ;
Sole, F (Institut de Recerca Contra la Leucèmia Josep Carreras) ;
Kern, Wolfgang (Mll Munich Leukemia Laboratory) ;
Platzbecker, Uwe (University Hospital Leipzig) ;
Arenillas, Leonor (Department of Hematology and Bone Marrow Transplantation. Hôpital Saint-Louis) ;
Fenaux, Pierre (Department of Hematology and Bone Marrow Transplantation. Hôpital Saint-Louis) ;
Haferlach, Torsten (Mll Munich Leukemia Laboratory) ;
Castellani, Gastone (Experimental. Diagnostic and Specialty Medicine. Dimes) ;
Della Porta, Matteo Giovanni (Department of Biomedical Sciences. Humanitas University)
PURPOSEMyelodysplastic syndromes (MDS) are heterogeneous myeloid neoplasms in which a risk-adapted treatment strategy is needed. Recently, a new clinical-molecular prognostic model, the Molecular International Prognostic Scoring System (IPSS-M) was proposed to improve the prediction of clinical outcome of the currently available tool (Revised International Prognostic Scoring System [IPSS-R]). [...]
2023 - 10.1200/JCO.22.01784
Journal of Clinical Oncology, Vol. 41 Núm. 15 (20 2023) , p. 2827-2842
|
|
3.
|
13 p, 1.2 MB |
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy : A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research
/
Schoettler, M.L. (Children's Healthcare of Atlanta) ;
Carreras, Enric (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Cho, Byung-Sik (The Catholic University of Korea) ;
Dandoy, Christopher E. (Cincinnati Children's Hospital Medical Center) ;
Ho, Vincent Trien Vinh (Dana-Farber Cancer Institute (Estats Units d'Amèrica)) ;
Jodele, Sonata (Cincinnati Children's Hospital Medical Center) ;
Moissev, I. (Pavlov First Saint Petersburg State Medical University) ;
Sańchez Ortega, Isabel (European Society for Bone Marrow Transplant) ;
Srivastava, Alok (Christian Medical College Vellore) ;
Atsuta, Yoshiko (Aichi Medical University) ;
Carpenter, Paul A. (Seattle Children's Hospital) ;
Koreth, John (Dana-Farber Cancer Institute (Estats Units d'Amèrica)) ;
Kröger, Nicolaus M. (Ohio State. University) ;
Ljungman, Per (Karolinska Institutet (Suècia)) ;
Page, Kristin M. (Medical College of Wisconsin) ;
Popat, Uday R. (The University of Texas MD Anderson Cancer Center) ;
Shaw, Bronwen E. (Medical College of Wisconsin) ;
Sureda Balari, Anna Maria (Institut Catala d'Oncologia-Hospital Duran i Reynals) ;
Soiffer, Robert J. (Dana-Farber Cancer Institute (Estats Units d'Amèrica)) ;
Vasu, Sumithira V. (Ohio State. University)
Transplantation-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized complication of hematopoietic cell transplantation (HCT) associated with significant morbidity and mortality. [...]
2023 - 10.1016/j.jtct.2022.11.015
Transplantation and Cellular Therapy, Vol. 29 Núm. 3 (march 2023) , p. 151-163
|
|
4.
|
11 p, 771.0 KB |
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
/
Cabrera Serrano, Antonio José (Instituto de Investigación Sanitaria de Granada) ;
Sánchez Maldonado, José Manuel (Instituto de Investigación Sanitaria de Granada) ;
ter Horst, Rob (CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences) ;
Macauda, Angelica (German Cancer Research Center) ;
García Martín, Paloma (Hospital Campus de la Salud (Granada)) ;
Benavente, Yolanda (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Landi, Stefano (Department of Biology. University of Pisa) ;
Clay-Gilmour, Alyssa (Department of Epidemiology & Biostatistics. Arnold School of Public Health. University of South Carolina) ;
Niazi, Yasmeen (Hopp Children's Cancer Center) ;
Espinet, Blanca (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Rodriguez-Sevilla, Juan Jose (Department of Leukemia. The University of Texas MD Anderson Cancer Center) ;
Pérez, Eva María (Hospital Campus de la Salud) ;
Maffei, Rossana (University of Modena and Reggio Emilia) ;
Blanco, Gonzalo (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Giaccherini, Matteo (Department of Biology. University of Pisa) ;
Cerhan, James R. (Department of Quantitative Health Sciences. Mayo Clinic) ;
Marasca, Roberto (Department of Medical and Surgical Sciences. University of Modena and Reggio Emilia. AOU Policlinico) ;
Lopez Nevot, Miguel Angel (Hospital Universitario Virgen de las Nieves (Granada)) ;
Chen-Liang, Tzu Hua (Hospital Universitario Morales Meseguer (Múrcia)) ;
Thomsen, Hauke (MSB Medical School Berlin) ;
Gámez, Irene (Hematology Department. Morales Meseguer University Hospital) ;
Campa, Daniele (Department of Biology. University of Pisa) ;
Moreno Aguado, Víctor (Facultat de Medicina. Universitat de Barcelona) ;
de Sanjosé, Silvia (Universitat de Barcelona) ;
Marcos-Gragera, Rafael (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
García-Álvarez, María Flor (Instituto de Investigación Biomédica de Salamanca) ;
Dierssen-Sotos, Trinidad (Universidad de Cantabria) ;
Jerez, Andrés (Vall d'Hebron Institut d'Oncologia) ;
Butrym, Aleksandra (Department of Cancer Prevention and Therapy. Medical University of Wrocław) ;
Norman, Aaron D. (Department of Quantitative Health Sciences. Mayo Clinic) ;
Luppi, Mario (University of Modena and Reggio Emilia) ;
Slager, Susan L. (Mayo Clinic) ;
Hemminki, Kari (Charles University in Prague) ;
Li, Yang (Hannover Medical School) ;
Berndt, Sonja I. (National Institutes of Health (Estats Units d'Amèrica)) ;
Casabonne, Delphine (Universitat de Barcelona) ;
Alcoceba, Miguel (Instituto de Investigación Biomédica de Salamanca) ;
Puiggros, Anna (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Netea, Mihai G. (Department for Immunology & Metabolism. University of Bonn) ;
Försti, Asta (Hopp Children's Cancer Center) ;
Canzian, Federico (German Cancer Research Center) ;
Sainz, Juan (Department of Biochemistry and Molecular Biology. Universidad de Granada)
Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. Although genome-wide association studies (GWAS) have uncovered the germline genetic component underlying CLL susceptibility, the potential use of GWAS-identified risk variants to predict disease progression and patient survival remains unexplored. [...]
2023 - 10.3390/ijms24098005
International journal of molecular sciences, Vol. 24 Núm. 9 (may 2023) , p. 8005
|
|
5.
|
18 p, 283.0 KB |
Conductas disruptivas en Educación Secundaria Obligatoria : análisis de factores intervinientes
/
Jurado de los Santos, Pedro (Universitat Autònoma de Barcelona. Departament de Pedagogia Aplicada) ;
Lafuente Carrasco, Alvaro (Universitat Autònoma de Barcelona. Departament de Pedagogia Aplicada) ;
Justiniano Domínguez, M. Delia (Universidad Católica Boliviana (Bolívia))
El presente estudio trata de identificar y valorar qué papel juegan los factores que intervienen en la manifestación de conductas disruptivas en el aula, en alumnos de un instituto público de Educación Secundaria, desde un planteamiento metodológico descriptivo-interpretativo ex post facto bajo el principio de triangulación de fuentes de información (alumnado y docentes), utilizando cuestionarios ad-hoc al efecto. [...] The aim of this work is to identify and evaluate the variables that take part in the disruptive behaviours of a classroom. In particular, in the framework of a Compulsory Secondary Education. The methodology used is descriptive-interpretative ex post facto. [...]
2020 - 10.18172/con.3827
Contextos Educativos. Revista de Educación, Núm. 25 (2020) , p. 25-236
|
|
6.
|
28 p, 468.9 KB |
Risk judgments in climbers : the role of difficulty, meteorological conditions, confidence and appropriate tools
/
Chamarro Lusar, Andrés (Universitat Autònoma de Barcelona) ;
Rovira Faixa, Tatiana (Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació) ;
Edo Izquierdo, Sílvia (Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació) ;
Fernández-Castro, Jordi (Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació)
Risk perception among climbers is a factor that can contribute to injury prevention. The purpose of this study was to analyze how expert climbers make judgments about potential risks to their safety. [...]
2019 - 10.1080/01490400.2018.1442266
Leisure Sciences, Vol. 41 Núm. 3 (2019) , p. 221-235
|
|
7.
|
|
8.
|
12 p, 608.0 KB |
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk
/
Gatell, José Mª (Hospital Clínic i Provincial de Barcelona) ;
Assoumou, Lambert (UPMC Univ Paris 06) ;
Moyle, Graeme (St Chelsea and Westminster Hospital) ;
Waters, Laura (Mortimer Market Center) ;
Johnson, Margaret (Royal Free Hospital) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Fox, Julie (Guys and St. Thomas Hospital) ;
Martinez, Esteban (Hospital Clínic i Provincial de Barcelona) ;
Stellbrink, Hans-Jürgen (ICH Study Centrum) ;
Guaraldi, Giovanni (University of Modena and Reggio Emilia) ;
Masia, Mar (Hospital General Universitario de Elche) ;
Gompels, Marl (Southmead Hospital) ;
De Wit, Stephane (Université Libre de Bruxelles) ;
Florence, Eric (Institute of Tropical Medicine) ;
Esser, Stefan (Universitatsklinikum) ;
Raffi, François (CHU de Nantes) ;
Pozniak, Anton L. (St Chelsea and Westminster Hospital) ;
Universitat Autònoma de Barcelona
To compare the efficacy, safety, and impact on lipid fractions of switching from a ritonavir-boosted protease inhibitor (PI/r) to a dolutegravir (DTG) regimen. HIV type 1-infected adults more than 50 years or with a Framingham score more than 10% were eligible if plasma HIV RNA less than 50 copies per ml for at least 24 weeks while on a PI/r regimen. [...]
2017 - 10.1097/QAD.0000000000001675
AIDS, Vol. 31 Núm. 18 (28 2017) , p. 2503-2514
|
|
9.
|
|
10.
|
5 p, 836.8 KB |
Epidemiological survey and risk factors associated with Paslahepevirus balayani in equines in Europe
/
Caballero-Gómez, Javier (Instituto de Salud Carlos III) ;
Rivero-Juárez, Antonio (Instituto de Salud Carlos III) ;
Cano-Terriza, David (Instituto de Salud Carlos III) ;
Fajardo, Tomás (Instituto de Salud Carlos III) ;
Buono, Francesco (Università degli Studi di Napoli Federico II. Department of Veterinary Medicine and Animal Productions) ;
José Cunilleras, Eduard (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
García, Jesús (Fethard Equine Hospital) ;
Alguacil, Eduardo (Uplands Way Vets) ;
Rivero, Antonio (Instituto de Salud Carlos III) ;
García-Bocanegra, Ignacio (Instituto de Salud Carlos III)
Paslahepevirus balayani (HEV) is an important emerging zoonotic virus in Europe. Although domestic pigs and wild boar are the main reservoirs of this pathogen, susceptibility to this virus has been confirmed in a growing number of animal species, including equines. [...]
2023 - 10.1016/j.onehlt.2023.100619
One Health, Vol. 17 (august 2023)
|
|